Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jarkko Ylanko

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Assay and Drug Development Technologies|October 1, 2015
A Versatile Cell Death Screening Assay Using Dye-Stained Cells and Multivariate Image AnalysisTony J Collins, Jarkko Ylanko, Fei Geng, et al.
DNA Repair|December 14, 2007
APLF (C2orf13) facilitates nonhomologous end-joining and undergoes ATM-dependent hyperphosphorylation following ionizing radiationChloe J Macrae, Richard D McCulloch, Jarkko Ylanko, et al.
Assay and Drug Development Technologies|August 9, 2018
Improved IRE1 and PERK Pathway Sensors for Multiplex Endoplasmic Reticulum Stress Assay Reveal Stress Response to Nuclear Dyes Used for Image SegmentationAdrien Nougarède, Chloé Tesnière, Jarkko Ylanko, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 28, 2019
Image-Based Analysis of Protein StabilityK Ashley Hickman, Santosh Hariharan, Jason De Melo, et al.
Molecular Oncology|May 31, 2018
miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulationChristianne Hoey, Jessica Ray, Jouhyun Jeon, et al.
Oncotarget|September 1, 2016
Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cellsSina Oppermann, Avery J Lam, Stephanie Tung, et al.
Iscience|January 1, 2026
High-content imaging of primary chronic lymphocytic leukemia cells predicts patient cohorts with distinct cellular drug responsesMark X Li, Glauber C Brito, Jarkko Ylanko, et al.
Blood|June 15, 2016
High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cellsSina Oppermann, Jarkko Ylanko, Yonghong Shi, et al.
Elife|October 23, 2019
Improving drug discovery using image-based multiparametric analysis of the epigenetic landscapeChen Farhy, Santosh Hariharan, Jarkko Ylanko, et al.
Science (New York, N.Y.)|November 17, 2007
Orchestration of the DNA-damage response by the RNF8 ubiquitin ligaseNadine K Kolas, J Ross Chapman, Shinichiro Nakada, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Assay and Drug Development Technologies|October 1, 2015
A Versatile Cell Death Screening Assay Using Dye-Stained Cells and Multivariate Image AnalysisTony J Collins, Jarkko Ylanko, Fei Geng, et al.
DNA Repair|December 14, 2007
APLF (C2orf13) facilitates nonhomologous end-joining and undergoes ATM-dependent hyperphosphorylation following ionizing radiationChloe J Macrae, Richard D McCulloch, Jarkko Ylanko, et al.
Assay and Drug Development Technologies|August 9, 2018
Improved IRE1 and PERK Pathway Sensors for Multiplex Endoplasmic Reticulum Stress Assay Reveal Stress Response to Nuclear Dyes Used for Image SegmentationAdrien Nougarède, Chloé Tesnière, Jarkko Ylanko, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 28, 2019
Image-Based Analysis of Protein StabilityK Ashley Hickman, Santosh Hariharan, Jason De Melo, et al.
Molecular Oncology|May 31, 2018
miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulationChristianne Hoey, Jessica Ray, Jouhyun Jeon, et al.
Oncotarget|September 1, 2016
Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cellsSina Oppermann, Avery J Lam, Stephanie Tung, et al.
Iscience|January 1, 2026
High-content imaging of primary chronic lymphocytic leukemia cells predicts patient cohorts with distinct cellular drug responsesMark X Li, Glauber C Brito, Jarkko Ylanko, et al.
Blood|June 15, 2016
High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cellsSina Oppermann, Jarkko Ylanko, Yonghong Shi, et al.
Elife|October 23, 2019
Improving drug discovery using image-based multiparametric analysis of the epigenetic landscapeChen Farhy, Santosh Hariharan, Jarkko Ylanko, et al.
Science (New York, N.Y.)|November 17, 2007
Orchestration of the DNA-damage response by the RNF8 ubiquitin ligaseNadine K Kolas, J Ross Chapman, Shinichiro Nakada, et al.
Pageof 2